Hemoshear Therapeutics, LLC

UEI
EYEHGTVJK567
CAGE
50LQ0
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Website
hemoshear.com
Founded
2008
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Hemoshear Therapeutics, LLC's 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Validation of targets for therapeutic intervention in nash Grant · R44DK115301 National Institute of Diabetes and Digestive and Kidney Diseases $1,840,807
Identification and validation of targets for therapeutic intervention in rare diseases of intermediary metabolism Grant · R44TR001407 National Center for Advancing Translational Sciences $1,605,601
Sbir phase II topic 314, title: validation of the hemoshear tumor microenvironment system for drug discovery and… Contract · HHSN261201500023C National Cancer Institute $1,985,657
Development of a divi platform for issue resolution in pre-clinical drug development. Grant · R44GM113304 National Institutes of Health $1,199,998
Validation of a human in vitro system of hepatic steatohepatitis Grant · R44DK100136 National Institutes of Health $1,210,475

Quick answers

What is Hemoshear Therapeutics, LLC's UEI?

Hemoshear Therapeutics, LLC's Unique Entity ID (UEI) in SAM.gov is EYEHGTVJK567.

What is Hemoshear Therapeutics, LLC's CAGE code?

Hemoshear Therapeutics, LLC's CAGE code is 50LQ0.

What is Hemoshear Therapeutics, LLC's primary NAICS code?

Hemoshear Therapeutics, LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Is Hemoshear Therapeutics, LLC registered in SAM.gov?

Hemoshear Therapeutics, LLC's SAM.gov registration expired on March 10, 2023.

What is Hemoshear Therapeutics, LLC's most recent federal award?

Hemoshear Therapeutics, LLC's most recent federal grant award is Validation of targets for therapeutic intervention in nash (R44DK115301), from National Institute of Diabetes and Digestive and Kidney Diseases, on August 1, 2017.

On GovTribe

See Hemoshear Therapeutics, LLC's full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login